Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant

Journal of Medical Microbiology

Volumn 52, Issue 3, 2003, Pages 223-228

  Zhu, Mingzhao ^a   Xu, Xuemei ^a   Liu, Hongwei ^b   Liu, Xiaojuan ^a   Wang, Sheng ^c,d   Dong, Fangtian ^c,d   Yang, Baoling ^b   Song, Guoxing ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF OPHTHALMOLOGY   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN D; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORNEA INJURY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EXPRESSION VECTOR; FEMALE; HELPER CELL; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CORNEA; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; PLASMIDS; SPLEEN; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 0037342494     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.04998-0     Document Type: Article

References (42)

1. Billaut-Mulot, O., Idziorek, T., Loyens, M., Capron, A. & Bahr, G. M. (2001). Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. Vaccine 19, 2803-2811.
2. Bourne, N., Stanberry, L. R., Bernstein, D. I. & Lew, D. (1996). DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 173, 800-807.
3. Bukowski, R. M. (2000). Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. Semin Oncol 27, 204-212.
4. Cantin, E. M., Hinton, D. R., Chen, J. & Openshaw, H. (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol 69, 4898-4905.
5. Cohen, A. D., Boyer, J. D. & Weiner, D. B. (1998). Modulating the immune response to genetic immunization. FASEB J 12, 1611-1626.
6. Corey, L., Langenberg, A. G., Ashley, R. & 14 other authors (1999). Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 282, 331-340.
7. Cruz, P. E., Khalil, P. L., Dryden, T. D., Chiou, H. C., Fink, P. S., Berberich, S. J. & Bigley, N. J. (1999). A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D. Vaccine 17, 1091-1099.
8. Fujioka, N., Akazawa, R., Ohashi, K., Fujii, M., Ikeda, M. & Kurimoto, M. (1999). Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73, 2401-2409.
9. Garcia, V. E., Uyemura, K., Sieling, P. A., Ochoa, M. T., Morita, C. T., Okamura, H., Kurimoto, M., Rea, T. H. & Modlin, R. L. (1999). IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 162, 6114-6121.
10. Geiger, K. D., Lee, M. S., Baugh, C. & Sarvetnick, N. E. (1995). Protective effects of interferon-γ in intraocular herpes simplex type 1 infection do not depend on major histocompatibility complex class I or class II expression. J Neurovirol 1, 405-409.
11. Ghiasi, H., Cai, S., Slanina, S., Nesburn, A. B. & Wechsler, S. L. (1995). Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res 28, 147-157.
12. Hara, I., Nagai, H., Miyake, H. & 8 other authors (2000). Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration. Cancer Gene Ther 7, 83-90.
13. Inoue, T., Inoue, Y., Nakamura, T. & 8 other authors (2000). Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci 41, 4209-4215.
14. Iwasaki, A., Stiernholm, B. J., Chan, A. K., Berinstein, N. L. & Barber, B. H. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158, 4591-4601.
15. Keadle, T. L., Laycock, K. A., Miller, J. K., Hook, K. K., Fenoglio, E. D., Francotte, M., Slaoui, M., Stuart, P. M. & Pepose, J. S. (1997). Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J Infect Dis 176, 331-338.
16. Kim, J. J., Bagarazzi, M. L., Trivedi, N. & 12 other authors (1997). Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol 15, 641-646.
17. Kim, J. J., Trivedi, N. N., Nottingham, L. K. & 13 other authors (1998). Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol 28, 1089-1103.
18. Kim, J. J., Simbiri, K. A., Sin, J. I. & 10 other authors (1999a). Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J Interferon Cytokine Res 19, 77-84.
19. Kim, J. J., Nottingham, L. K., Tsai, A. & 9 other authors (1999b). Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-γ, IL-12, or IL-18 gene adjuvants. J Med Primatol 28, 214-223.
20. Kim, J. J., Yang, J. S., Dentchev, T., Dang, K. & Weiner, D. B. (2000). Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J Interferon Cytokine Res 20, 487-498.
21. Kohno, K., Kataoka, J., Ohtsuki, T., Suemoto, Y., Okamoto, I., Usui, M., Ikeda, M. & Kurimoto, M. (1997). IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158, 1541-1550.
22. Kremer, L., Dupre, L., Wolowczuk, I. & Locht, C. (1999). In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J Immunol 163, 3226-3231.
23. Landolfo, S., Gribaudo, G., Angeretti, A. & Gariglio, M. (1995). Mechanisms of viral inhibition by interferons. Pharmacol Ther 65, 415-442.
24. McKendall, R. R. (1983). Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier. J Gen Virol 64, 1965-1972.
25. Nash, A. A. & Cambouropoulos, P. (1993). The immune response to herpes simplex virus. Semin Virol 4, 181-186.
26. Nash, A. D., Lofthouse, S. A., Barcham, G. J., Jacobs, H. J., Ashman, K., Meeusen, E. N., Brandon, M. R. & Andrews, A. E. (1993). Recombinant cytokines as immunological adjuvants. Immunol Cell Biol 71, 367-379.
27. Neumann-Haefelin, D., Sundmacher, R., Frey, H. & Merk, W. (1985). Recombinant HuIFN-γ prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-α 2. Med Microbiol Immunol (Berl) 174, 81-86.
28. Notkins, A. L. (1974). Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol 11, 478-483.
29. Ohkusu, K., Yoshimoto, T., Takeda, K., Ogura, T., Kashiwamura, S., Iwakura, Y., Akira, S., Okamura, H. & Nakanishi, K. (2000). Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection. Infect Immun 68, 2449-2456.
30. Okamura, H., Nagata, K., Komatsu, T. & 8 other authors (1995). A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63, 3966-3972.
31. Opal, S. M., Wherry, J. C. & Grint, P. (1998). Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis 27, 1497-1507.
32. Price, R. W., Walz, M. A., Wohlenberg, C. & Notkins, A. L. (1975). Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science 188, 938-940.
33. Rager-Zisman, B. & Allison, A. C. (1976). Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol 116, 35-40.
34. Reiter, Z. (1993). Interferon - a major regulator of natural killer cell-mediated cytotoxicity. J Interferon Res 13, 247-257.
35. Scott, P. & Trinchieri, G. (1997). IL-12 as an adjuvant for cell-mediated immunity. Semin Immunol 9, 285-291.
36. Sethi, K. K., Omata, Y. & Schneweis, K. E. (1983). Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J Gen Virol 64, 443-447.
37. Sin, J. I., Kim, J. J., Ugen, K. E., Ciccarelli, R. B., Higgins, T. J. & Weiner, D. B. (1998). Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur J Immunol 28, 3530-3540.
38. + T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol 162, 2912-2921.
39. Tanigawa, M., Bigger, J. E., Kanter, M. Y. & Atherton, S. S. (2000). Natural killer cells prevent direct anterior-to-posterior spread of herpes simplex virus type 1 in the eye. Invest Ophthalmol Vis Sci 41, 132-137.
40. Tovey, M. G., Meritet, J. F., Guymarho, J. & Maury, C. (1999). Mucosal cytokine therapy: marked antiviral and antitumor activity. J Interferon Cytokine Res 19, 911-921.
41. Ushio, S., Namba, M., Okura, T. & 13 other authors (1996). Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156, 4274-4279.
42. Zhu, M. Z., Liu, H. W., Liu, X. J., Han, Y. H., Yang, B. L. & Song, G. X. (2002). Construction of herpes simplex virus type 1 glycoprotein D DNA vaccine and its preliminary study. Acta Acad Med Sin 24, 67-70.